Finland· FI-REL-REL989
Avitcid
A tretinoin product containing tretinoin, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Tretinoin is registered in 6 of 19 countries.
Countries holding a registration under ATC D10AD01 (tretinoin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Tretinoin · ATC D10AD01
6 / 19 countries
- Canada
- Finlandprice
- Germany
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Tretinoin
- Manufacturer
- Orion Corporation Orion Pharma
- Country
- Finland (FI)
- ATC code
- D10AD01
- ATC class
- Tretinoin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
9 interactions on record for tretinoin.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tretinoin · interactions on record
9 records
- 1 severe
- 8 moderate
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Salicylic acidD01AE12moderate
- IsotretinoinD10AD04moderate
- Benzoyl peroxideD10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tretinoin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAltrenoBausch Health US, LLC
- United KingdomActicin 0.025% creamKyowa Kirin Ltd
- CanadaJAMP TRETINOINJAMP PHARMA CORPORATION
- FranceEFFEDERM 0,05 %, crèmeLABORATOIRES BAILLEUL (LUXEMBOURG)
- SpainNEOCARE 4 mg/g CREMAIndustrial Farmaceutica Cantabria S.A.
- NorwayCordes VASIchthyol-Gesellschaft
- NetherlandsVesanoid, zachte capsules 10 mgEureco-Pharma B.V.
- BelgiumTreclinax 10 mg/g - 0.25 mg/gViatris Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Vesanoid
- Belgium · Vesanoid
- Germany · Cordes Vas, Vesanoid
- Spain · Neocare, Retirides
- France · Effederm, Ketrel
- United Kingdom (Northern Ireland) · Tretinoin Neon Healthcare, Vesanoid
- Croatia · Vesanoid
- Ireland · Vesanoid
- Italy · Tretinoina Same Savoma Medicinali, Vesanoid
- Malta · Ketrel
- Netherlands · Vesanoid
- Poland · Vesanoid
- Portugal · Ketrel, Vesanoid
- Slovakia · Vesanoid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9d588631-003e-422b-a61c-1d21161b1c73 GET /v1/drugs/9d588631-003e-422b-a61c-1d21161b1c73?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "linimentti",
"route": null,
"ddd_unit": null,
"strength": "0.5 mg/ml",
"atc_label": "tretinoiini",
"ma_number": "6916",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL989",
"authorised_at": "1974-09-25"
}See everything about tretinoin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.